This inventor holds 1 USPTO granted patent. Top assignee: Japanese Foundation for Cancer Research. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Kazuki Kumada: Innovator in Cancer Research
Introduction
Kazuki Kumada is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of cancer research through his innovative work. His research focuses on developing tools that can enhance our understanding of cell division and its implications for cancer treatment.
Latest Patents
Kazuki Kumada holds a patent for a "Fluorescent separase activity sensor." The primary objective of this invention is to provide a separase sensor that visualizes separase activity in living cells. This technology aims to develop a functional analysis system for cell division and to create a simple screening method for anticancer agents. The separase sensor utilizes two types of fluorescent proteins that differ in fluorescence wavelength, strategically placed at both ends of an amino acid sequence containing a separase cleavage site. This allows for precise timing and location tracking of separase activity within a cell, facilitating the analysis of cell division and the screening of potential anticancer agents.
Career Highlights
Kazuki Kumada is affiliated with the Japanese Foundation for Cancer Research, where he continues to advance his research. His work is pivotal in the ongoing battle against cancer, providing new insights and methodologies that could lead to more effective treatments.
Collaborations
Kazuki collaborates with esteemed colleagues such as Toru Hirota and Norihisa Shindo. Their combined expertise enhances the research efforts at the Japanese Foundation for Cancer Research.
Conclusion
Kazuki Kumada's innovative contributions to cancer research through his patented separase activity sensor exemplify the potential of scientific advancements in improving cancer treatment methodologies. His work continues to inspire and pave the way for future innovations in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile